Latest Regulatory Approval News

Optiscan Imaging has reached an 84-case milestone in its live digital pathology study with Australian Clinical Labs, testing the InForm platform across a broad range of tissue types and disease settings. The data may support future regulatory submissions and commercial discussions, but the announcement does not disclose diagnostic accuracy metrics or regulatory approval.

St Barbara will sell its remaining New Simberi interest and Tabar Islands exploration exposure to Lingbao for A$453 million in cash, while retaining royalties over future production. The deal could leave the gold developer with about A$880 million in cash, but completion still depends on regulatory and potentially shareholder approvals.

Exultant Mining has reported its first consolidated annual results since listing, recording a $1.526 million loss and holding $3.50 million in cash at 30 June 2026. Exploration has advanced across Black Hammer and Peak View, but the company remains dependent on future funding and assay results to justify its portfolio.

OncoSil Medical has moved closer to local production after contract manufacturer Cyclotek secured ISO 13485 certification for its quality management system. Production at the Macquarie Park facility remains targeted for the end of 2Q FY27, subject to further regulatory approval.

Nelson Resources has lodged a Notice of Intent to collect up to 1,000 short tons of remnant mineralised material from the Orleans Mine in Nevada for bulk-scale metallurgical testing. The program could test whether laboratory recovery results translate to commercial-mill conditions, but remains subject to approval, bonding and the appointment of a third-party mill.

Kelsian’s proposed sale of its Tourism Portfolio to Journey Beyond has cleared the ACCC, removing a major regulatory condition before completion. The transaction still requires FIRB approval, contract consents and other conditions, with completion expected in 1HFY27.

Sunrise Energy Metals has put its Syerston scandium project on a stronger financial footing, ending FY2026 with A$115.4 million in cash and a conditional US$400 million debt commitment. The project still faces a decisive sequence of tests: final investment approval, binding offtake agreements, financing conditions and construction execution.

Emperor Energy has signed a term sheet to secure the Valaris 107 jack-up rig for its Judith-2 appraisal well, targeted for April 2027. The deal commits US$3.5 million before the full drilling contract is finalised, while environmental approval remains outstanding.

OncoSil Medical has secured $5.6 million from its three largest institutional investors to fund commercial launches of its OncoSil device in the United States and Australia. The commitments follow FDA and TGA approvals and would lift pro-forma cash to $12.1 million once completed.

Paterson Resources is set to start an extensive drilling campaign at its Grace Gold Project, aiming to upgrade its 200,000-ounce inferred gold resource and extend high-grade mineralisation along a 1.3km strike in the Paterson Province.

Elixinol Wellness has finalized the divestment of its US operations to Ananda Health, securing upfront and deferred payments totaling approximately A$465,000. This move refocuses the company on its Australian health and wellness portfolio while reducing exposure to US regulatory risks.

Argent Minerals has kicked off its first-ever drilling campaign at the Trunkey Creek Gold Project in New South Wales, targeting a priority zone within a 4.7km gold-mineralised corridor beneath historic workings.